Vir Biotechnology, Inc. (VIR)
8.39
-0.48
(-5.41%)
USD |
NASDAQ |
Nov 20, 16:00
8.38
-0.01
(-0.12%)
After-Hours: 20:00
Vir Biotechnology Price : 8.39 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 8.77 | 8.915 | 8.34 | 8.39 | 3.090M |
| Nov 19, 2026 | 9.25 | 9.40 | 8.87 | 8.87 | 1.887M |
| Nov 18, 2026 | 9.17 | 9.37 | 9.015 | 9.15 | 2.155M |
| Nov 17, 2026 | 9.58 | 9.75 | 9.03 | 9.25 | 3.484M |
| Nov 16, 2026 | 9.85 | 10.04 | 9.57 | 9.58 | 6.782M |
| Nov 13, 2026 | 10.46 | 10.70 | 9.71 | 9.96 | 16.66M |
| Nov 12, 2026 | 12.90 | 12.96 | 12.02 | 12.12 | 2.061M |
| Nov 11, 2026 | 13.22 | 13.43 | 12.94 | 13.13 | 1.292M |
| Nov 10, 2026 | 13.66 | 13.74 | 13.10 | 13.15 | 1.301M |
| Nov 09, 2026 | 13.15 | 14.38 | 13.00 | 13.64 | 7.124M |
| Nov 06, 2026 | 11.30 | 12.44 | 11.30 | 12.21 | 1.897M |
| Nov 05, 2026 | 11.92 | 12.16 | 10.98 | 11.02 | 2.935M |
| Nov 04, 2026 | 11.68 | 11.81 | 11.17 | 11.77 | 2.805M |
| Nov 03, 2026 | 11.10 | 11.38 | 11.10 | 11.22 | 1.554M |
| Nov 02, 2026 | 11.36 | 11.55 | 11.00 | 11.00 | 1.378M |
| Oct 30, 2026 | 11.63 | 11.84 | 11.18 | 11.30 | 1.270M |
| Oct 29, 2026 | 11.69 | 12.19 | 11.55 | 11.75 | 1.422M |
| Oct 28, 2026 | 11.11 | 11.94 | 11.11 | 11.93 | 1.558M |
| Oct 27, 2026 | 11.00 | 11.63 | 10.86 | 11.57 | 1.974M |
| Oct 26, 2026 | 10.64 | 11.10 | 10.60 | 11.04 | 1.587M |
| Oct 23, 2026 | 10.36 | 10.59 | 10.03 | 10.57 | 1.694M |
| Oct 22, 2026 | 10.51 | 10.75 | 10.18 | 10.43 | 987074.0 |
| Oct 21, 2026 | 10.80 | 11.02 | 10.55 | 10.57 | 1.137M |
| Oct 20, 2026 | 10.19 | 10.88 | 10.14 | 10.74 | 1.343M |
| Oct 19, 2026 | 10.04 | 10.30 | 9.96 | 10.21 | 1.309M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 195.00 |
| Vaxcyte, Inc. | 55.39 |
| Oncolytics Biotech, Inc. | 0.3501 |
| Sangamo Therapeutics, Inc. | 0.106 |
| Sarepta Therapeutics, Inc. | 13.33 |
Price Related Metrics
| PS Ratio | 4.328 |
| Price to Book Value | 1.586 |
| Earnings Yield | -14.97% |
| Market Cap | 1.421B |